Skip to main content
P

Precision Biosensor Inc. — Investor Relations & Filings

Ticker · 335810 ISIN · KR7335810008 KO Manufacturing
Open in API
Filings indexed 172 across all filing types
Latest filing 2022-03-24 Director's Dealing
Country KR South Korea
Listing KO 335810

About Precision Biosensor Inc.

https://precision-bio.com/

Precision Biosensor Inc. is an in vitro diagnostics (IVD) company that develops, manufactures, and commercializes clinical diagnostic solutions. The company specializes in point-of-care testing (POCT), providing optimized systems for on-site diagnosis. Its product portfolio includes analyzing devices and diagnostic reagents for both human and animal health. Precision Biosensor utilizes advanced technologies, such as time-resolved fluorescence (TRF), for the sensitive and accurate detection of various disease biomarkers in immuno-diagnosis and clinical chemistry applications, including cardiac markers.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of an executive (Seunghoon Lee) at Precision Bio, specifically noting a change due to the exercise of stock options. This type of filing is a standard regulatory requirement for insider trading/ownership reporting, which corresponds to the 'Director's Dealing' category.
2022-03-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as a 'Director's Dealing' or 'Insider Trading' report) where company executives disclose changes in their personal shareholdings. The content details the reporter (Hwang Kyu-Youn), the company (Precision Bioscience), and the specific transaction (stock option exercise). This fits the 'Director's Dealing' (DIRS) category perfectly.
2022-03-24 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed, including financial statement approval, dividend status, director appointments, and board compensation. This document reports the official outcomes of the shareholder votes held at the AGM, which aligns perfectly with the definition for Declaration of Voting Results & Voting Rights Announcements.
2022-03-23 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of a specific outside director (Seo Jeong-wook) for Precision Bio Co., Ltd. This falls under the category of board management and changes in corporate governance structure.
2022-03-23 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees and executives, including the number of shares, exercise price, and valuation methodology. Since this document pertains to the issuance of new rights/shares (stock options) rather than a general regulatory announcement or a report publication notice, it falls under the category of share issuance or capital changes.
2022-03-23 Korean
주식매수선택권행사
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Precision Bioscience) regarding the exercise of stock options (주식매수선택권행사). It details the number of shares exercised, the exercise price, the individuals involved (directors and employees), and the impact on total shares. This type of disclosure regarding the issuance of new shares resulting from stock option exercises falls under the category of 'Share Issue/Capital Change'.
2022-03-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.